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Summary A nested case-control study was undertaken in the Maribo County cohort of 27,811 women with
negative Pap smears. Sixty women who later developed invasive cervical cancer constituted the cases, and five
matched controls were selected from the cohort for each case. A total of 633 previous, negative smears for the
cases and controls were reviewed independently by two pathologists. The review showed misclassification to be
frequent in these smears collected in the period 1966-82. Thirty-five smears were considered positive at the
review. The misclassification was differential in respect to the women's later disease status. The odds ratio for
patients compared with controls for having at least one positive smear was 22.12 (95%CI 7.54-64.94). We
were unable to identify specific characteristics of misclassified smears coming from later cases. Koilocytosis/
dyskeratosis, herpes virus changed cells and hyperkeratosis were equally rare in smears from patients and
controls. The Maribo County data indicate that the fraction of preventable cases of invasive cervical cancer in
women aged 30-64 within the first 5 years after a negative smear could be increased from 62-72% to
83-86%, if misclassification of true positive smears could be eliminated. As a rough estimate, this would be at
the cost of a 2% increase in the work load. It should be remembered that there is a large element of
extrapolation in applying these results based on relatively poor quality specimens from 1966-82 as compared
to a modem screening service.
Women from Maribo County, Denmark, were followed in a
cohort study to evaluate the risk of developing invasive
cervical cancer after cytologically normal Pap smears (Lynge
& Poll, 1986). The region had an organised screeing pro-
gramme and the study included data both on smears taken in
the programme and on smears taken in the clinical work.
The study showed that the five-year risk of developing
invasive cervical cancer was 48% lower in women after one
negative smear than in women from control regions where
screening was not offered, and the five-year risk in women
after 2-4 negative smears was 69% lower.
These results from Maribo County cohort thus illustrate
the overall protective effect ofcervical cancer screening found
in the IARC collaborative study (IARC working group,
1986), of which it was a part. Cervical cancer was, however,
not completely eliminated as a disease, and 60 cases of
invasive cervical cancers were diagnosed during the years
1966-84 in the Maribo County cohort of 27,811 women,
who originally had negative smears. Could these cancer cases
also have been prevented, and a higher efficiency of the
widespread screening activity thus have been achieved? The
quality of the cytopathology is an important element in an
answer to this question, and review of Pap smears from
cervical cancer patients has previously revealed misclassi-
fication, e.g. Mitchell et al. (1990).
The Maribo County cohort came from a region where the
98,000 negative smears belonging to the cohort members
were stored in one place. We have therefore undertaken a
case-control study, nested in the cohort of women from the
Maribo County, to evaluate whether misclassification of Pap
smears occurred more often for women who later developed
an invasive cervical cancer than for other women, to identify
possible characteristics of misclassified smears belonging to
future patients, and to evaluate the potential influence of
misclassification on the outcome of a screening programme.
Materials and methods
Cohort
In the cohort study all smears taken in the Maribo County in
the years 1966-1982 among women born 1918-1952 were
registered. Both smears taken within the organised screening
programme and all other smears taken as part of the clinical
work by general practitioners, private gynaecologists, and
hospital wards were included.
All women with at least one smear were followed up for
death and emigration in the Central Population Register, for
cases of invasive cervical cancer in the computerised files of
the local department of pathology and in the Danish Cancer
Register, and for operations causing surgical removal of the
cervix uteri in the Danish Hospital Discharge Register and in
questionnaire data collected at the screening rounds. A
cohort was thus identified of 27,811 women, who originally
had negative smears.
Cases
A total of 60 cases of invasive cervical cancer was registered
in this cohort when the follow-up was extended to include
1984. These 60 women constitute the cases.
Controls
For each case, five women were selected as controls from the
cohort. Those five women were selected, who came closest to
the case in date of birth, had the first negative smear in the
same year as the case, had the same number of negative
smears, had not developed a precancerous lesion of the cervix
uteri, and had been followed up with the cervix uteri intact
for at least the same time interval since the last negative
smear as the case.
Histology review
Slides from the paraffin blocks based on which the original
diagnoses were made were reviewed by two pathologists (EA
and PP). Only those cases for which invasive growth was
confirmed at the review remained as cases in the further
analysis.
Cytology review
All previous negative smears for cases and controls were
reviewed blindly by two pathologists (EA and PP). Slides
with dots from the cytotechnicians' original evaluation were
registered, and the dots were removed with ethanol before
the review. Smears were classified as being satisfactory or
unsatisfactory for evaluation of CIN. A satisfactory smear
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should accurately reflect the underlying histology, and it
should contain cells from the whole of the transformation
zone (Coleman et al., in press). Satisfactory smears were
classified into negative smears and positive smears. Negative
smears were smears with no cells indicating an underlying
cervical premalignant or malignant lesion. Positive smears
were all other satisfactory smears. The results of the two
reviews were compared, and a common evaluation was made
for those smears considered at the review as being positive by
one pathologist and unsatisfactory or negative by the other.
The smears were also classified as to whether they showed
indication of condyloma (koilocytotic and/or dyskeratotic
cells), contained herpes virus changed cells, or showed
significant hyperkeratosis.
Statistical analysis
To evaluate whether misclassification of Pap smears occurred
more often for cases than for controls each woman was
classified by her smear with the most severe diagnosis at the
review in the categories: positive, unsatisfactory, and
negative. Cases and controls were compared with two sets of
odds ratios, one for the presence of at least one positive
smear (vs negative + unsatisfactory smears only), and an-
other for the presence of at least one positive or unsatisfac-
tory smear (vs negative smears only). The odds ratios were
estimated using conditional logistic regression for matched
data (Breslow & Day, 1980).
To evaluate whether patients more often than controls had
smears with condyloma, herpes virus, or hyperkeratosis each
woman was classified by her smear with the most severe
diagnosis in respect to each of these three criteria in: positive,
unsatisfactory, and negative. Odds ratios were calculated to
compare patients and controls as described above.
Smears classified as positive in the consensus review were
compared according to the presence or absence of a number
ofcharacteristics, and their status as coming from patients or
controls.
The probability of developing an invasive cervical cancer
for women aged 30-64 during the first 5 years after a
negative smear was calculated as: Ps= l-(exp(-I ni/pi)),
where ni is the observed number of cases in year i after last
negative smear, and pi the person-years at risk in the same
year. The fraction of preventable cases was calculated as
(l-PS/P.s) x 100%, where Pn. is the 5 year disease probability
in women not offered screening.
Results
Histology review
Slides from the original paraffin blocks could be reviewed for
all the 49 patients diagnosed at the department of pathology
in Maribo County and also for the 11 patients diagnosed in
other parts of Denmark. Nineteen cases were originally
classified as microinvasive carcinoma, 32 cases as squamous
cell carcinoma, and nine cases as adenocarcinoma. The result
of the review is shown in Table I. In seven of the 60 cases no
invasive growth was found at the review, and data are
reported in the following only for the 53 confirmed cases.
Cytology review
Of the 53 cases, 28 had one previous negative smear before
the date of diagnosis, 11 had two smears, six had three
smears, six had four smears, one person had six smears, and
one person had eight previous negative smears. Thus giving a
total of 106 previous negative smears. Control persons were
matched on number of previous negative smears and they in
total had 530 smears. These 636 smears were all taken in
Maribo County in the period 1966-82, and 630 were
analysed at the local department of pathology and six by a
private pathologist. Three of the smears could not be found





Diagnosis Micro- Squamous Adeno-
at review invasive cell carcinoma Total
No invasion 7 0 0 7
Microinvasive 11 1 0 12
Squamous cell 0 31 0 31
carcinoma
Adenocarcinoma 0 0 6 6
Adenosquamous 1 0 3 4
carcinoma
Total 19 32 9 60
Table II Classification of 633 originally negative Pap smears in two
independent cytology reviews
Pathologist A
Unsatisfactory Negative Positive Total
Pathologist B
Unsatisfactory 43 45 4 92
Negative 93 371 23 487
Positive 5 36 13 54
Total 141 452 40 633
Table III Classification of633 originally negativePapsmears bymain
diagnostic group and by status as coming from a case or a control
person
Path A Path B Botha Consensusb
Cases
Unsatisfactory % 24 14 26 26
Negative 54 75 44 55
Positive 28 17 36 25
Total 106 106 106 106
Unsatisfactory % 23% 13% 25% 25%
Positive % 26% 16% 34% 24%
Controls
Unsatisfactory % 117 78 155 155
Negative 398 412 327 362
Positive 12 37 45 10
Total 527 527 527 527
Unsatisfactory % 22% 15% 29% 29%
Positive % 2% 7% 9% 2%
apositive, ifpositive by atleast onepathologist. Unsatisfactory, ifnot
positive, and unsatisfactory by at least one pathologist. bAccording to
theconsensusreview, orifthiswasnotmade,positive,ifpositivebyboth
pathologists, and for the remaining smears unsatisfacory, if
unsatisfactory by at least one pathologist.
Table II shows the result of the two independent reviews of
the 633 originally negative smears. The two pathologists
agreed in their evaluations for 427 ( = 68%). Only 371
(= 59%) smears were considered negative by both path-
ologists at the review. A consensus review was made for the
68 smears considered positive by one pathologist only. As a
result of the reevaluation 22 smears were classified as positive
and 46 smears as negative.
Table III shows the distribution of smears from case and
control persons, respectively, by the main diagnostic group as
given by each of the two pathologists, by combining the
reviews from the two pathologists to give the most severe
diagnosis, and from the consensus review. The percentage of
positive smears was higher for smears from cases, in the
range 16-34%, than for smears from controls, in the range
2-9%, in all four reviews. There was less variation between
the smears from cases and from controls in the percentages
of unsatisfactory, which varied between 13-25% among
smears from cases and 15-29% among smears from con-
trols.370 E. LYNGE et al.
Table IV shows the distribution of case and control per-
sons, respectively, by main diagnostic group for the smear
with the most severe diagnosis at the cytology review, and
the odds ratios estimated in the matched analysis. The OR
for having at least one positive smear (vs negative + unsatis-
factory smears only) was statistically significantly increased in
cases compared with controls. The ORs varied, however,
considerably between the two independent reviews, thus
being OR = 30.82 (95%CI 9.18-103.47) for pathologist A,
and OR = 2.62 (95%CI 1.29-5.32) for pathologist B. The
result of the consensus review was OR = 22.12 (95%CI
7.54-64.94), and thus close to that for pathologist A. The
OR for having at least one positive or unsatisfactory smear
(vs negative smears only) was significantly increased for cases
compared with controls in the review by pathologist A,
OR = 4.36 (95%CI 2.24-8.51), and in the consensus review,
OR = 2.16 (95%CI 1.13-4.15). The OR = 1.53 (95%CI
0.83-2.81) in the review by pathologist B did not reach
statistical significance.
Table V shows the 35 smears that were considered positive
at the consensus review distributed by various characteristics
and by status as coming from a case or a control person.
Twenty-two of these smears were initially found positive by
one pathologist only, and comments on difficulties in the
interpretation of the smear due to few cells, inflammation or
autolysis were given on the review forms for 27 of these
smears. There were, however, no differences concerning these
quality aspects between smears coming from cases and con-
trols. Twenty-three out of the 35 smears were taken as part
of the organised screening programme, and the remaining
smears were taken in the clinical work. There was no
difference among smears coming from cases and controls in
this respect either. Twenty-two of the 35 smears have a
'higher' grade than atypical, and there was a slight tendency
for this to be more common among smears from cases than
from controls. The difference was, however, not statistically
significant. For 16 out of the 35 smears a suspicion had
originally been raised by the cytotechnicians indicated by the
presence ofdots on the glasses. There was a tendency for this
to be more common for smears coming from cases than from
controls, the difference did not, however, reach statistical
significance.
Table VI shows that koilocytosis/dyskeratosis was ob-
served in 11 smears, herpes virus changed cells in two smears,
and hyperkeratosis in 18 smears, when a smear was con-
sidered positive, if it was classified as such by at least one of
the two pathologists. Table VII shows that the ORs for these
conditions were not increased in cases compared with con-
trols. An OR = 0.50 (95%CI 0.06-3.91) was thus found for
koilocytosis/dyskeratosis, an OR = 5.00 (95%CI 0.31-79.94)
was found for herpes virus changed cells, and an OR = 1.00
(95%CI 0.28-3.61) was found for hyperkeratosis.
Discussion
The Maribo County had an organised screening programme
from 1967 to 1982, and the county is at present one of the
areas in Denmark with a relatively low incidence of cervical
cancer (Lynge et al., 1992). Sixty cases of invasive cervical
cancer were, however, registered in the cohort of 27,811
women with negative smears. At the histology review
invasive growth could be confirmed in specimens from 53 of
these cases only, and the difference was in part explained by
terminology problems, as three of the reclassified patients
had been diagnosed by a pathologist, who used a non-
standardised term for microinvasive carcinoma. The seven
misdiagnosed patients have not developed cervical cancer
later. The 53 cases are considered to represent the true
incidence in the cohort, although it must be taken into
account that a histology review was not made of originally
non-invasive cases.
A total of 633 previously negative smears were found in
the nested case-control study, where five matched control
women were selected for each confirmed case. The subjective
element in the interpretation ofPap smears was illustrated by
the fact, that the two pathologists agreed in their evaluation
for 68% of these smears only. The smears were collected in
the period 1966-82, and the quality was in general low
compared to modern standard. One fourth of these smears
were thus considered unsatisfactory in the consensus review,
compared to only 1-2% of all smears in present screening
programmes (Vejle Amtskommune, 1987; Kobenhavns Amts-
kommune, 1987).
These quality limitations probably also gave room for the
considerable difference between the two pathologists in
identification of positive smears. The total number of smears
reclassified as positive was 40 for pathologist A, and 54 for
pathologist B, but only 13 of these smears were identified by
both pathologists. Of the 53 patients, 43% were classified by
Table IV Classification of 318 persons who originally had negative Pap smears by the
smearwith themost severediagnosisa attheCytology review and bystatusascaseofcontrol
person
Path A Path B Bothb Consensusb
Cases
Unsatisfactory 14 10 12 13
Negative 16 28 13 19
Positive 23 15 28 21
Total 53 53 53 53
Unsatisfactory % 26% 19% 23% 25%
Positive % 43% 28% 53% 40%
Controls
Unsatisfactory % 88 64 104 116
Negative 166 166 119 139
Positive 11 35 42 10
Total 265 265 265 265
Unsatisfactory % 33% 24% 39% 44%
Positive % 4% 13% 16% 4%
Odds ratio
Positive
(negative + unsatisfactory = 1)
OR 30.82 2.62 6.50 22.12
95% CI 9.18-103.47 1.29-5.32 3.28-12.88 7.54-64.94
Positive + unsatisfactory
(negative = 1)
OR 4.36 1.53 2.79 2.16
95% CI 2.24-8.51 0.83-2.81 1.37-5.69 1.13-4.15
aIn the order: positive, unsatisfactory, negative. bIndividual smears are classified as in
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Table V Pap smears classified positive in the consensus review by




Present Absent Present Absent P
Positivity reported 9 16 4 6 0.87
initially by both
pathologists
Quality problemsa 19 6 8 2 0.85
reported
Smear taken as 18 7 5 5 0.40
part of screening
programme
Positive smear 18 7 4 6 0.17
of higher grade
than atypical
Suspicion originally 14 11 2 8 0.12
raised by cyto-
technician
'Few cells, inflammation of autolysis.
Table VI Classification of 633 originally negative Pap smears by
evidence of viral infection and hyperkeratosis at the cytology review'
and by status as coming from a case or a control person
Koilocytosisl
dyskeratosis Herpes virus Hyperkeratosis
Cases
Unsatisfactory 25 25 25
Negative 80 80 78
Positive 1 1 3
Total 106 106 106
Unsatisfactory % 24% 24% 24%
Positive % 1% 1% 3%
Controls
Unsatisfactory 116 116 115
Negative 401 410 397
Positive 10 1 15
Total 527 527 527
Unsatisfactory % 22% 22% 22%
Positive % 2% 0% 3%
'Individual smears areclassified as: positive, ifpositive by atleast one
pathologist, and as: unsatisfactory, ifnotpositive, andunsatisfactory by
at least one pathologist.
pathologist A as having at least one misclassified positive
smear, and 28% by pathologist B. Both of these estimates
fall within the wide range from 8% (Mitchell et al., 1988) to
64% (Attwood et al., 1985) previously reported in the
predominantly small series of patients with invasive cervical
cancer for whom the previous negative smears have been
reviewed (Rylander, 1977; Gad & Koch, 1978; Berkowitz et
al., 1979; Berkeley et al., 1980; Holman et al., 1981; Mor-
ell et al., 1982; Walker et al., 1983: Paterson et al., 1984; Gay
et al., 1985; Attwood et al., 1985; Graff et al., 1987; Mit-
chell et al., 1988; Mitchell et al., 1990).
Women with invasive cervical cancer had an increased risk
compared with controls for having at least one misclassified
positive smear. The risk estimate varied, however, 10-fold,
from 30.82 in the review made by pathologist A, to 2.62 in
the review made by pathologist B. The answer to the initial
question in this study, whether misclassification of Pap
smears is in fact differential in respect to later disease status,
is therefore yes, but the size of the risk estimate is highly
dependent on the reviewer. The risk estimate was 22.12 in the
consensus review.
In addition to looking for misclassified positive smears, the
analysis also included estimation of the risk for mis-
classification for referral to diagnostic follow up. In this
respect both positive and unsatisfactory smears were con-
sidered misclassified, as both types of smears should initiate
diagnostic follow up. The risk estimates for patients com-
Table VII Classification of 318 persons originally had negative Pap
smearsbythemostsevereaevidenceofviralinfectionandhyperkeratosis
inatleast one smearatthecytologyreviewandbystatus ascomingfrom
a case or a control person
Koilocytosisl
dyskeratosis Herpes virusb Hyperkeratosis'
Cases
Unsatisfactory 19 20 20
Negative 33 32 30
Positive 1 1 3
Total 53 53 53
Unsatisfactory % 36% 38% 38%
Positive % 2% 2% 6%
Controls
Unsatisfactory 88 92 88 Negative 167 172 162 Positive 10 1 16 Total 265 265 265
Unsatisfactory % 33% 35% 33% Positive % 4% -% 6%
Odds ratio
Positive
(negative + unsatisfactory = 1)
OR 0.50 5.00 1.00
95% CI 0.06-3.91 0.31-79.94 0.28-3.61
Positive + unsatisfactory
(negative = 1)
OR 1.04 1.26 1.26
95% CI 0.53-2.03 0.65-2.43 0.65-2.43
aIn the order: positive, unsatisfactory, negative. bIndividual smears
are classified as in Table VI.
pared with controls here varied only 3-fold, from 4.36 in the
review made by pathologist A, to 1.53 in the review made by pathologist B, and it was 2.16 in the consensus review.
In comparing the results for 'misclassified positive' and
'misclassified referral' it is noteworthy, that the patients in
the consensus review had a 22-fold increased risk for the first
type of misclassification, whereas they had only a 2-fold risk
for the second type of misclassification. If all positive smears
were initially correctly identified 21 out of the 53 missed
cancer cases would have been identified. When considering
whether this would be desirable or not one also has to take
the potential costs into consideration. We have evaluated the
costs from the proportion in the controls of originally
negative smears identified as positive at the review. This
proportion is 2%. If correctly identified as positive, all of
these smears would need to be followed up with at least one
further smear or biopsy. As a rough estimate of the costs of
a correct identification of all positive smears, we have thus
used a 2% increase in the work load.
If all 'referral' smears were initially correctly identified a
maximum of 34 out of the 53 missed cancer cases would have
been identified. This would, however, have been approx-
imately at the cost of a 31% increase in the work load
(= proportion of 'referral' smears in the controls). This
would imply that one third of the screening participants
should be retested, and this would be unacceptable both for
ethical and economic reasons.
We were thus not able to identify specific characteristics
for misclassified smears belonging to future patients com-
pared with misclassified smears belonging to women who
remained disease free. Furthermore, only a minority of the
smears was found to be positive for koilocytosis/dyskeratosis,
herpes virus changed cells, or hyperkeratosis, and the risks
for the presence of these conditions were not increased in
patients compared with controls. In the control group, 4% of
the originally negative smears were considered positive for
koilocytosis/dyskeratosis at the review. This corresponds well
with the previously reported proportions of HPV-related
morphological signs of 0-12.3% in smears from women
without CIN (Sanjose et al., 1992).
Misclassification indicates the existence of avoidable cases
ofinvasive cervical cancer, and it is possible from the Maribo372 E. LYNGE et al.
Table VIII Cases ofinvasive cervical cancer in women 30-64 years in Maribo County during the first 5 years










Registered cases 17 0.0015 48% 16 0.0009 69%
Confirmed cases 13 0.0011 62% 15 0.0008 72%
Confirmed cases, 5 0.0004 86% 8 0.0005 83%
without a positive
smear ( = unavoidable
cases)
See text for definition, probability without screening = 0.0029.
No screening rate
I Registered rate
-*- Unavoidable rate a
b
2 3 4
Years since last negative smear
Figure 1 Registered and 'unavoidable' incidence of invasive cervical cancer in the Maribo County cohort aged 30-64 by time
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County data to estimate the potential improvement of the
protective effect of a screening programme, if the mis-
classification of positive smears could be eliminated. Table
VIII shows the estimates for the fraction ofpreventable cases
of invasive cervical cancer in women 30-64 years within the
first 5 years after one and 2-4 negative smears, respectively.
The baseline used for comparison was the incidence of
invasive cervical cancer in a similar population without
screening, giving a 5-year probability of 0.0029 (Lynge &
Poll, 1986). For one negative smear, the estimated fraction of
prevented cases was 48% based on the registered cases.
Invasive growth was, however, not confirmed in all of these
cases, and the 'true' estimate for the fraction of prevented
cases was thus 62%. As the baseline used for comparison
represents symptomatic, clinically detected cases, it is
assumed here that a histologic review would not change the
baseline.
If none of the positive smears from the confirmed cases
had been missed, the fraction of preventable cases would
have been 86%. The equivalent fraction for women with 2-4
negative smears would have been 83%. The potential impact
of improved cytology was, as expected, greater in women
with one -wegative smear only, 24% (= 86%-62%), than in
women with 2-4 negative smears, 11% (= 83%-72%). The
instability of these estimates due to small numbers should be
noted. Figure 1 shows the incidence curves based on which
the disease probabilities have been calculated.
Screening for cervical cancer has been widespread in many
countries for the last 20-30 years. In Denmark, women have
on average a smear taken every second year (Sundheds-
stryrelsen, 1986), and the incidence of invasive cervical cancer
has decreased, but is still at a level of 16.4 per 100,000
(World Standard Population) (Storm et al., 1991).
Several measures on the organisational level can contribute
to improve the efficiency of screening programmes (Chamber-
lain, 1986). The present study indicates that with an im-
proved cytopathology which eliminates misclassification of
positive smears the proportion of prevented cancers increases
from 62-72% to 83-86%. As a rough estimate, this can be
achieved with a 2% increase in the work load. The study also
indicates that although the protection might be even better if
all unsatisfactory smears were correctly identified, this would
imply a 31% increase in the cost, and would thus be unac-
ceptable for both ethical and economic reasons. It should be
remembered that there is a large element of extrapolation in
applying these results based on relatively poor quality speci-
mens from 1966-82 as compared to a modern screening
service.
Abbreviations: CIN - cervical intraepithelial neoplasia; IARC - Inter-
national Agency for Research on Cancer; OR- Odds ratio
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